Recent Advancements in Typhoid Fever Vaccination Strategies: A Review

Abstract

strategies, focusing on the efficacy of next-generation vaccines and the complexity of their real-world implementation. A comprehensive review of academic literature was undertaken to delineate the landscape of current and emerging prophylactic interventions. The major findings indicate that the introduction of Typhoid Conjugate Vaccines (TCVs) represents a paradigm shift, demonstrating superior immunogenicity, longer-lasting protection, and the critical advantage of suitability for use in infants, addressing a significant vulnerability in high-burden settings. Furthermore, these advancements are pivotal in combating the alarming rise of multidrug-resistant S. Typhi strains, offering a robust tool to mitigate antimicrobial resistance spread. Major recommendations arising from this synthesis underscore the need for accelerated and equitable TCV deployment integrated with water, sanitation, and hygiene (WASH) improvements, along with continued investment in vaccine development and optimized delivery research, especially in resource-limited contexts. In conclusion, the current trajectory in typhoid vaccination, particularly with TCVs, provides a potent pathway towards disease control and potential elimination. The implications of these findings are substantial, offering evidence-based guidance for policymakers to prioritize TCV introduction as a high-impact public health measure to reduce morbidity, mortality, and the societal burden of this ancient yet persistent disease.